Drug product
DOXOrubicin Hydrochloride Injection, USP, 10 mg / 5 mL (2 mg / mL), 5 mL fill in a 6 mL vial, Single Dose Vial, Rx only, Sterile, Fresenius Kabi, Lake Zurich, IL 60047. NDC: 63323-883-05
D-0105-2021
Product summary
- Event
- Event 86765
- Status
- Terminated
- Classification
- Class III
- Quantity
- 16,986 vials
- Official record key
drug-enforcement:D-0105-2021
Official wording
Reason: Cross Contamination with Other Products: trace amounts of octreotide found during testing
Code information: Batch: 6120525, exp 11/2020
Distribution pattern: Nationwide USA and Puerto Rico
Derived failure modes
-
Unknown
Cross Contamination with Other Products: trace amounts of octreotide found during testing